Genetic Testing Market: Global Industry Analysis and Forecast (2023-2029)

Genetic Testing Market is anticipated to reach US$ 39.73 Bn. by 2029 from US$ 18.43 Bn. in 2022 at a CAGR of 11.6% during a forecast period. Genomic data is crucial to a precision medicine approach to healthcare; it is feasible to decode DNA into its basic sequences to view its functional information as data, allowing researchers, bioinformaticians, and physicians to decode the properties of a person's DNA. The genetic testing industry is growing driven by increased consumer knowledge, evolving culture of consumer empowerment, and a need for highly individualized services. Companies that provide these services, however, are increasingly concerned about data privacy and scientific validity. A rare disease, defined as a disorder affecting less than one in every 2,000 individuals, affects around 300 million people globally. While genetic factors underlie 80% of such illnesses, effective genetic testing and diagnosis remain a hurdle. Sequencing, a crucial driver of precision medicine, is becoming more cost-effective. The cost of reading the full human genome has reduced by an order of magnitude, from $10,000 in 2011 to around $1,000 in 2022, because of a variety of technical, scientific, and frontline operational breakthroughs. The Genetic Testing Market is segmented based on Type, Disease, Technology, and Region. The growth of different segments assists the report users in gaining knowledge of the many growth variables estimated to be prevalent across the market and developing various tactics to assist in identifying core application areas and the gap in the target market. The research examines the market in-depth and includes valuable insights, facts, historical data, and scientifically backed and industry-validated market figures. Estimates are also provided based on a suitable set of assumptions and approaches. Genetic Testing Market To know about the Research Methodology :- Request Free Sample Report

Genetic Testing Market Dynamics

The growth is accompanied by an increase in the incidence of genetic illnesses and a decrease in the cost of genetic testing. In 2022, there were around 6, 00,920 cancer deaths in the United States. Patients are expected to be more aware of the need for early illness detection, which would lead to faster treatment and a lower death rate. The increased prevalence of illnesses such as cancer, cystic fibrosis, Alzheimer's disease, and other genetic disorders likely lead to an increase in the number of individuals undergoing genetic testing for early diagnosis, fuelling the growth of the Global Genetic Testing Market. The increased emphasis by governments throughout the world on regulating and raising knowledge about genetic testing has resulted in a speedier acceptance of these tests around the world. The increased R&D investment, along with the strong market presence of the firm's leading competitors, has produced a high entry barrier for new entrants. Product design innovation, quality improvement, and strong distribution partnerships are critical elements for maintaining a competitive advantage in the market. For example, in August 2021, Ricoh Company Ltd. and DNA Chip Research Inc. released RICOH Standard DNA Series EGFR mutation Type001, a reference DNA plate to be utilized in blood-based genomics. Genetic Testing Market 2Direct-to-consumer genetic testing kits are becoming increasingly popular in countries such as the United States, China, and Japan. With increased technology adoption, awareness initiatives, and cost reductions, the market for DTC-GT (Direct-to-consumer genetic testing) kits is expected to grow significantly throughout the forecast period. Furthermore, underdeveloped markets such as India and other emerging countries are likely to provide a profitable opportunity for firms trying to establish a foothold in the genetic testing market. As a result, given the increased burden of chronic illnesses, technology advancements and a shift toward customized therapy are expected to provide significant results.

Genetic Testing Market Segment Analysis

By Disease, over the forecast period, the cancer disease segment is expected to grow at CAGR of xx%. Genetic testing can help determine a person's risk of acquiring several forms of malignancies throughout a lifetime. Inherited variations and mutations in the DNA sequence, which can lead to excessive cell growth and tumor/cancer, can be tested via genetic testing. For example, genetic testing for PALB2 linked to an increased risk of breast and pancreatic cancer, CHEK2 linked to breast and colorectal cancers, BRIP1 linked to ovarian cancer, and RAD51C and RAD51D linked to breast and colorectal cancers. The rising global cancer burden and rising global awareness of preventative diagnosis and tailored medication are the major factors driving the cancer sector market throughout the forecast period. According to Globocan 2022, the number of new cancer cases in 2022 is expected to reach 19,292,789, with almost 9,958,133 cancer fatalities. According to the International Agency for Research on Cancer, the number of new cancer cases is expected to reach 30.2 million by 2040. (IARC). Thus, genetic testing assists in determining if cancer runs in the family and the risk factors connected with the development of malignancies in the future among individuals. Genetic Testing Market1By Technology, The molecular testing segment dominated the genetic testing market in 2022 and is projected to continue to do so during the forecast period. The fact that molecular testing is the most widely utilized technique for genetic testing contributes to the segment's growth. Genetic tests such as carrier testing, diagnostic testing, predictive and presymptomatic testing, and others, for example, employ the technology. Furthermore, molecular testing is recommended because it may be utilized to assess DNA gains or losses that are not identifiable by standard chromosomal examination.

Genetic Testing Market Regional Insight

In 2022, the global genetic testing market is dominated by North America. The demand for genetic testing in the global market is growing in line with an increase in the number of diseases caused by genetic abnormalities and rapid technological advancements. In the North American area, the United States led the genetic testing market. The United States' growth may be attributed to upgrading infrastructure to facilitate genetic testing, governmental support for direct-to-consumer (DTC) genetic testing, as well as increased insurance coverage, and lower genetic test costs. Asia-Pacific is expected to grow at a faster rate throughout the forecast period. The main countries, such as China and India, are driving the growth pace. The Asia-Pacific market is being driven by factors such as increased R&D expenditure, a huge patient pool, and rising government financing. Other factors driving the Global Genetic Testing Market include developments in genetic testing technology, increasing prevalence of genetic illnesses, and increased awareness about disease early detection. Report Objectives: • Landscape analysis of the Genetic Testing Market • competitive benchmarking • Past and current status of the industry with the forecasted market size and trends • Evaluation of potential key players that include market leaders, followers, and new entrants • Technology trends • Potential impact of micro-economic factors of the market • External and Internal factors affecting market have been analyzed The report also helps in understanding the Genetic Testing Market dynamics, structure by analysing the market segments and project the Genetic Testing Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Genetic Testing Market make the report investor’s guide.

Genetic Testing Market Scope: Inquire before buying

Genetic Testing Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $18.43 Bn
Forecast Period 2022 to 2029 CAGR: 11.6 % Market Size in 2029: US $ 39.73 Bn.
Segments Covered: by Type Carrier Testing Diagnostic Testing Newborn Screening Predictive and PR symptomatic Testing Prenatal Testing Nutrigenomic Testing
by Disease Alzheimer's Diseases Cancer Cystic Fibrosis Sickle Cell Anemia Duchenne Muscular Dystrophy Thalassemia’s Huntington's Disease Special Diseases Others
by Technology Cytogenetic Testing Biochemical Testing Molecular Testing

Genetic Testing Market by Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Genetic Testing Market: Key Players

1.  Abbott Laboratories 2. Roche Diagnostics 3. Myriad Genetics, Inc. 4. Thermo Fisher Scientific, Inc. 5. Agilent Technologies, Inc. 6. Hologic, Inc. 7. Illumina, Inc. 8. QIAGEN N.V. 9. Cepheid 10. Quest Diagnostics 11. Precipio Inc. 12. Ariosa Diagnositic Inc. 13. Sequenom Inc. 14. 23andMe 15. Bayer Diagnostics 16. Biocartis 17. BioHelix 18. BioMerieux 19. BGI 20. Counsyl 21. deCODEme 22. Genentech 23. Genomictree 24. IntegraGen 25. LabCorp Diagnostic Frequently Asked Questions 1. What is the projected market size & growth rate of Genetic Testing Market? Ans- Genetic Testing Market was valued at USD 18.43 billion in 2022 and is projected to reach USD 39.73 billion by 2029, growing at a CAGR of 11.6% during the forecast period. 2. What are the key driving factor for the growth of Genetic Testing Market? Ans- The growth is accompanied by an increase in the incidence of genetic illnesses and a decrease in the cost of genetic testing 3. Which Region accounted for the largest Genetic Testing Market share? Ans- In 2022, the global genetic testing market is dominated by North America. 4. What makes Asia Pacific a Lucrative Market for Genetic Testing Market? Ans- the Asia-Pacific market is being driven by factors such as increased R&D expenditure, a huge patient pool, and rising government financing. 5. What are the top players operating in Genetic Testing Market? Ans- Abbott Laboratories, Roche Diagnostics, Myriad Genetics, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Hologic, Inc., and Illumina, Inc.
1. Genetic Testing Market: Research Methodology 2. Genetic Testing Market Introduction 2.1. Study Assumption and Market Definition 2.2. Scope of the Study 2.3. Executive Summary 3. Genetic Testing Market: Dynamics 3.1. Genetic Testing Market Trends by Region 3.1.1. North America Genetic Testing Market Trends 3.1.2. Europe Genetic Testing Market Trends 3.1.3. Asia Pacific Genetic Testing Market Trends 3.1.4. Middle East and Africa Genetic Testing Market Trends 3.1.5. South America Genetic Testing Market Trends 3.2. Genetic Testing Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Genetic Testing Market Drivers 3.2.1.2. North America Genetic Testing Market Restraints 3.2.1.3. North America Genetic Testing Market Opportunities 3.2.1.4. North America Genetic Testing Market Challenges 3.2.2. Europe 3.2.2.1. Europe Genetic Testing Market Drivers 3.2.2.2. Europe Genetic Testing Market Restraints 3.2.2.3. Europe Genetic Testing Market Opportunities 3.2.2.4. Europe Genetic Testing Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Genetic Testing Market Drivers 3.2.3.2. Asia Pacific Genetic Testing Market Restraints 3.2.3.3. Asia Pacific Genetic Testing Market Opportunities 3.2.3.4. Asia Pacific Genetic Testing Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Genetic Testing Market Drivers 3.2.4.2. Middle East and Africa Genetic Testing Market Restraints 3.2.4.3. Middle East and Africa Genetic Testing Market Opportunities 3.2.4.4. Middle East and Africa Genetic Testing Market Challenges 3.2.5. South America 3.2.5.1. South America Genetic Testing Market Drivers 3.2.5.2. South America Genetic Testing Market Restraints 3.2.5.3. South America Genetic Testing Market Opportunities 3.2.5.4. South America Genetic Testing Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Technology Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis For Genetic Testing Market 3.8. Analysis of Government Schemes and Initiatives For Genetic Testing Market 3.9. The Global Pandemic Impact on Genetic Testing Market 3.10. Advances and Innovations in Genetic Testing 3.10.1. Artificial Intelligence in Genetic Analysis 3.10.2. Integration of Genetic Testing in Mainstream Healthcare 4. Genetic Testing Market: Global Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 4.1. Genetic Testing Market Size and Forecast, by Type (2023-2030) 4.1.1. Carrier Testing 4.1.2. Diagnostic Testing 4.1.3. Newborn Screening 4.1.4. Predictive and PR symptomatic Testing 4.1.5. Prenatal Testing 4.1.6. Nutrigenomic Testing 4.2. Genetic Testing Market Size and Forecast, by Disease (2023-2030) 4.2.1. Alzheimer's Diseases 4.2.2. Cancer 4.2.3. Cystic Fibrosis 4.2.4. Sickle Cell Anemia 4.2.5. Duchenne Muscular Dystrophy 4.2.6. Thalassemia’s 4.2.7. Huntington's Disease 4.2.8. Special Diseases 4.2.9. Others 4.3. Genetic Testing Market Size and Forecast, by Technology (2023-2030) 4.3.1. Cytogenetic Testing 4.3.2. Biochemical Testing 4.3.3. Molecular Testing 4.4. Genetic Testing Market Size and Forecast, by Region (2023-2030) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. Middle East and Africa 4.4.5. South America 5. North America Genetic Testing Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 5.1. North America Genetic Testing Market Size and Forecast, by Type (2023-2030) 5.1.1. Carrier Testing 5.1.2. Diagnostic Testing 5.1.3. Newborn Screening 5.1.4. Predictive and PR symptomatic Testing 5.1.5. Prenatal Testing 5.1.6. Nutrigenomic Testing 5.2. North America Genetic Testing Market Size and Forecast, by Disease (2023-2030) 5.2.1. Hospitals 5.2.2. Ambulatory Surgery Centres 5.2.3. Physiotherapy Centres and Clinics 5.3. North America Genetic Testing Market Size and Forecast, by Technology (2023-2030) 5.3.1. Knee Injuries 5.3.2. Shoulder Injuries 5.3.3. Foot and Ankle Injuries 5.3.4. Elbow and Wrist Injuries 5.3.5. Back and Spine Injuries 5.3.6. Hip and Groin Injuries 5.3.7. Other Injuries 5.4. North America Genetic Testing Market Size and Forecast, by Country (2023-2030) 5.4.1. United States 5.4.1.1. United States Genetic Testing Market Size and Forecast, by Type (2023-2030) 5.4.1.1.1. Carrier Testing 5.4.1.1.2. Diagnostic Testing 5.4.1.1.3. Newborn Screening 5.4.1.1.4. Predictive and PR symptomatic Testing 5.4.1.1.5. Prenatal Testing 5.4.1.1.6. Nutrigenomic Testing 5.4.1.2. United States Genetic Testing Market Size and Forecast, by Disease (2023-2030) 5.4.1.2.1. Hospitals 5.4.1.2.2. Ambulatory Surgery Centres 5.4.1.2.3. Physiotherapy Centres and Clinics 5.4.1.3. United States Genetic Testing Market Size and Forecast, by Technology (2023-2030) 5.4.1.3.1. Knee Injuries 5.4.1.3.2. Shoulder Injuries 5.4.1.3.3. Foot and Ankle Injuries 5.4.1.3.4. Elbow and Wrist Injuries 5.4.1.3.5. Back and Spine Injuries 5.4.1.3.6. Hip and Groin Injuries 5.4.1.3.7. Other Injuries 5.4.2. Canada 5.4.2.1. Canada Genetic Testing Market Size and Forecast, by Type (2023-2030) 5.4.2.1.1. Body Reconstruction Products 5.4.2.1.2. Body Support and Recovery Products 5.4.2.1.3. Accessories 5.4.2.2. Canada Genetic Testing Market Size and Forecast, by Disease (2023-2030) 5.4.2.2.1. Hospitals 5.4.2.2.2. Ambulatory Surgery Centres 5.4.2.2.3. Physiotherapy Centres and Clinics 5.4.2.3. Canada Genetic Testing Market Size and Forecast, by Technology (2023-2030) 5.4.2.3.1. Knee Injuries 5.4.2.3.2. Shoulder Injuries 5.4.2.3.3. Foot and Ankle Injuries 5.4.2.3.4. Elbow and Wrist Injuries 5.4.2.3.5. Back and Spine Injuries 5.4.2.3.6. Hip and Groin Injuries 5.4.2.3.7. Other Injuries 5.4.3. Mexico 5.4.3.1. Mexico Genetic Testing Market Size and Forecast, by Type (2023-2030) 5.4.3.1.1. Body Reconstruction Products 5.4.3.1.2. Body Support and Recovery Products 5.4.3.1.3. Accessories 5.4.3.2. Mexico Genetic Testing Market Size and Forecast, by Disease (2023-2030) 5.4.3.2.1. Hospitals 5.4.3.2.2. Ambulatory Surgery Centres 5.4.3.2.3. Physiotherapy Centres and Clinics 5.4.3.3. Mexico Genetic Testing Market Size and Forecast, by Technology (2023-2030) 5.4.3.3.1. Knee Injuries 5.4.3.3.2. Shoulder Injuries 5.4.3.3.3. Foot and Ankle Injuries 5.4.3.3.4. Elbow and Wrist Injuries 5.4.3.3.5. Back and Spine Injuries 5.4.3.3.6. Hip and Groin Injuries 5.4.3.3.7. Other Injuries 6. Europe Genetic Testing Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 6.1. Europe Genetic Testing Market Size and Forecast, by Type (2023-2030) 6.2. Europe Genetic Testing Market Size and Forecast, by Disease (2023-2030) 6.3. Europe Genetic Testing Market Size and Forecast, by Technology (2023-2030) 6.4. Europe Genetic Testing Market Size and Forecast, by Country (2023-2030) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Genetic Testing Market Size and Forecast, by Type (2023-2030) 6.4.1.2. United Kingdom Genetic Testing Market Size and Forecast, by Disease (2023-2030) 6.4.1.3. United Kingdom Genetic Testing Market Size and Forecast, by Technology (2023-2030) 6.4.2. France 6.4.2.1. France Genetic Testing Market Size and Forecast, by Type (2023-2030) 6.4.2.2. France Genetic Testing Market Size and Forecast, by Disease (2023-2030) 6.4.2.3. France Genetic Testing Market Size and Forecast, by Technology (2023-2030) 6.4.3. Germany 6.4.3.1. Germany Genetic Testing Market Size and Forecast, by Type (2023-2030) 6.4.3.2. Germany Genetic Testing Market Size and Forecast, by Disease (2023-2030) 6.4.3.3. Germany Genetic Testing Market Size and Forecast, by Technology (2023-2030) 6.4.4. Italy 6.4.4.1. Italy Genetic Testing Market Size and Forecast, by Type (2023-2030) 6.4.4.2. Italy Genetic Testing Market Size and Forecast, by Disease (2023-2030) 6.4.4.3. Italy Genetic Testing Market Size and Forecast, by Technology (2023-2030) 6.4.5. Spain 6.4.5.1. Spain Genetic Testing Market Size and Forecast, by Type (2023-2030) 6.4.5.2. Spain Genetic Testing Market Size and Forecast, by Disease (2023-2030) 6.4.5.3. Spain Genetic Testing Market Size and Forecast, by Technology (2023-2030) 6.4.6. Sweden 6.4.6.1. Sweden Genetic Testing Market Size and Forecast, by Type (2023-2030) 6.4.6.2. Sweden Genetic Testing Market Size and Forecast, by Disease (2023-2030) 6.4.6.3. Sweden Genetic Testing Market Size and Forecast, by Technology (2023-2030) 6.4.7. Austria 6.4.7.1. Austria Genetic Testing Market Size and Forecast, by Type (2023-2030) 6.4.7.2. Austria Genetic Testing Market Size and Forecast, by Disease (2023-2030) 6.4.7.3. Austria Genetic Testing Market Size and Forecast, by Technology (2023-2030) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Genetic Testing Market Size and Forecast, by Type (2023-2030) 6.4.8.2. Rest of Europe Genetic Testing Market Size and Forecast, by Disease (2023-2030) 6.4.8.3. Rest of Europe Genetic Testing Market Size and Forecast, by Technology (2023-2030) 7. Asia Pacific Genetic Testing Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 7.1. Asia Pacific Genetic Testing Market Size and Forecast, by Type (2023-2030) 7.2. Asia Pacific Genetic Testing Market Size and Forecast, by Disease (2023-2030) 7.3. Asia Pacific Genetic Testing Market Size and Forecast, by Technology (2023-2030) 7.4. Asia Pacific Genetic Testing Market Size and Forecast, by Country (2023-2030) 7.4.1. China 7.4.1.1. China Genetic Testing Market Size and Forecast, by Type (2023-2030) 7.4.1.2. China Genetic Testing Market Size and Forecast, by Disease (2023-2030) 7.4.1.3. China Genetic Testing Market Size and Forecast, by Technology (2023-2030) 7.4.2. S Korea 7.4.2.1. S Korea Genetic Testing Market Size and Forecast, by Type (2023-2030) 7.4.2.2. S Korea Genetic Testing Market Size and Forecast, by Disease (2023-2030) 7.4.2.3. S Korea Genetic Testing Market Size and Forecast, by Technology (2023-2030) 7.4.3. Japan 7.4.3.1. Japan Genetic Testing Market Size and Forecast, by Type (2023-2030) 7.4.3.2. Japan Genetic Testing Market Size and Forecast, by Disease (2023-2030) 7.4.3.3. Japan Genetic Testing Market Size and Forecast, by Technology (2023-2030) 7.4.4. India 7.4.4.1. India Genetic Testing Market Size and Forecast, by Type (2023-2030) 7.4.4.2. India Genetic Testing Market Size and Forecast, by Disease (2023-2030) 7.4.4.3. India Genetic Testing Market Size and Forecast, by Technology (2023-2030) 7.4.5. Australia 7.4.5.1. Australia Genetic Testing Market Size and Forecast, by Type (2023-2030) 7.4.5.2. Australia Genetic Testing Market Size and Forecast, by Disease (2023-2030) 7.4.5.3. Australia Genetic Testing Market Size and Forecast, by Technology (2023-2030) 7.4.6. Indonesia 7.4.6.1. Indonesia Genetic Testing Market Size and Forecast, by Type (2023-2030) 7.4.6.2. Indonesia Genetic Testing Market Size and Forecast, by Disease (2023-2030) 7.4.6.3. Indonesia Genetic Testing Market Size and Forecast, by Technology (2023-2030) 7.4.7. Malaysia 7.4.7.1. Malaysia Genetic Testing Market Size and Forecast, by Type (2023-2030) 7.4.7.2. Malaysia Genetic Testing Market Size and Forecast, by Disease (2023-2030) 7.4.7.3. Malaysia Genetic Testing Market Size and Forecast, by Technology (2023-2030) 7.4.8. Vietnam 7.4.8.1. Vietnam Genetic Testing Market Size and Forecast, by Type (2023-2030) 7.4.8.2. Vietnam Genetic Testing Market Size and Forecast, by Disease (2023-2030) 7.4.8.3. Vietnam Genetic Testing Market Size and Forecast, by Technology (2023-2030) 7.4.9. Taiwan 7.4.9.1. Taiwan Genetic Testing Market Size and Forecast, by Type (2023-2030) 7.4.9.2. Taiwan Genetic Testing Market Size and Forecast, by Disease (2023-2030) 7.4.9.3. Taiwan Genetic Testing Market Size and Forecast, by Technology (2023-2030) 7.4.10. Rest of Asia Pacific 7.4.10.1. Rest of Asia Pacific Genetic Testing Market Size and Forecast, by Type (2023-2030) 7.4.10.2. Rest of Asia Pacific Genetic Testing Market Size and Forecast, by Disease (2023-2030) 7.4.10.3. Rest of Asia Pacific Genetic Testing Market Size and Forecast, by Technology (2023-2030) 8. Middle East and Africa Genetic Testing Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030 8.1. Middle East and Africa Genetic Testing Market Size and Forecast, by Type (2023-2030) 8.2. Middle East and Africa Genetic Testing Market Size and Forecast, by Disease (2023-2030) 8.3. Middle East and Africa Genetic Testing Market Size and Forecast, by Technology (2023-2030) 8.4. Middle East and Africa Genetic Testing Market Size and Forecast, by Country (2023-2030) 8.4.1. South Africa 8.4.1.1. South Africa Genetic Testing Market Size and Forecast, by Type (2023-2030) 8.4.1.2. South Africa Genetic Testing Market Size and Forecast, by Disease (2023-2030) 8.4.1.3. South Africa Genetic Testing Market Size and Forecast, by Technology (2023-2030) 8.4.2. GCC 8.4.2.1. GCC Genetic Testing Market Size and Forecast, by Type (2023-2030) 8.4.2.2. GCC Genetic Testing Market Size and Forecast, by Disease (2023-2030) 8.4.2.3. GCC Genetic Testing Market Size and Forecast, by Technology (2023-2030) 8.4.3. Nigeria 8.4.3.1. Nigeria Genetic Testing Market Size and Forecast, by Type (2023-2030) 8.4.3.2. Nigeria Genetic Testing Market Size and Forecast, by Disease (2023-2030) 8.4.3.3. Nigeria Genetic Testing Market Size and Forecast, by Technology (2023-2030) 8.4.4. Rest of ME&A 8.4.4.1. Rest of ME&A Genetic Testing Market Size and Forecast, by Type (2023-2030) 8.4.4.2. Rest of ME&A Genetic Testing Market Size and Forecast, by Disease (2023-2030) 8.4.4.3. Rest of ME&A Genetic Testing Market Size and Forecast, by Technology (2023-2030) 9. South America Genetic Testing Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030 9.1. South America Genetic Testing Market Size and Forecast, by Type (2023-2030) 9.2. South America Genetic Testing Market Size and Forecast, by Disease (2023-2030) 9.3. South America Genetic Testing Market Size and Forecast, by Technology (2023-2030) 9.4. South America Genetic Testing Market Size and Forecast, by Country (2023-2030) 9.4.1. Brazil 9.4.1.1. Brazil Genetic Testing Market Size and Forecast, by Type (2023-2030) 9.4.1.2. Brazil Genetic Testing Market Size and Forecast, by Disease (2023-2030) 9.4.1.3. Brazil Genetic Testing Market Size and Forecast, by Technology (2023-2030) 9.4.2. Argentina 9.4.2.1. Argentina Genetic Testing Market Size and Forecast, by Type (2023-2030) 9.4.2.2. Argentina Genetic Testing Market Size and Forecast, by Disease (2023-2030) 9.4.2.3. Argentina Genetic Testing Market Size and Forecast, by Technology (2023-2030) 9.4.3. Rest Of South America 9.4.3.1. Rest Of South America Genetic Testing Market Size and Forecast, by Type (2023-2030) 9.4.3.2. Rest Of South America Genetic Testing Market Size and Forecast, by Disease (2023-2030) 9.4.3.3. Rest Of South America Genetic Testing Market Size and Forecast, by Technology (2023-2030) 10. Global Genetic Testing Market: Competitive Landscape 10.1. MMR Competition Matrix 10.2. Competitive Landscape 10.3. Key Players Benchmarking 10.3.1. Company Name 10.3.2. Service Segment 10.3.3. End-user Segment 10.3.4. Revenue (2023) 10.3.5. Company Locations 10.4. Leading Genetic Testing Market Companies, by Market Capitalization 10.5. Market Structure 10.5.1. Market Leaders 10.5.2. Market Followers 10.5.3. Emerging Players 10.6. Mergers and Acquisitions Details 11. Company Profile: Key Players 11.1. Abbott Laboratories 11.1.1. Company Overview 11.1.2. Business Portfolio 11.1.3. Financial Overview 11.1.4. SWOT Analysis 11.1.5. Strategic Analysis 11.1.6. Recent Developments 11.2. Roche Diagnostics 11.3. Myriad Genetics, Inc. 11.4. Thermo Fisher Scientific, Inc. 11.5. Agilent Technologies, Inc. 11.6. Hologic, Inc. 11.7. Illumina, Inc. 11.8. QIAGEN N.V. 11.9. Cepheid 11.10. Quest Diagnostics 11.11. Precipio Inc. 11.12. Ariosa Diagnositic Inc. 11.13. Sequenom Inc. 11.14. 23andMe 11.15. Bayer Diagnostics 11.16. Biocartis 11.17. BioHelix 11.18. BioMerieux 11.19. BGI 11.20. Counsyl 11.21. deCODEme 11.22. Genentech 11.23. Genomictree 11.24. IntegraGen 11.25. LabCorp Diagnostic 12. Key Findings 13. Industry Recommendations

About This Report

Report ID 10781
Category Healthcare
Published Date DEC 2023
Updated Date
  • INQUIRE BEFORE BUYING